首页> 外文期刊>The Open Toxicology Journal >Toxicity Studies of Sidha Medicine - Rasagandhi Mezhugu
【24h】

Toxicity Studies of Sidha Medicine - Rasagandhi Mezhugu

机译:OP Siddha Medicine的毒性研究-Rasakanthi蜡

获取原文
       

摘要

Sidha medicines which are popular in Southern parts of India have significant quantity of heavy metals. It is claimed that mode of preparation of these drugs reduces their toxicities. However toxicity studies of Sidha preparations are seldom carried out. In the present study we have evaluated toxicity of Rasagandhi Mezhugu (RM), a Sidha preparation in Wistar rats. Drug was administered orally as single dose (acute) and sixty doses (chronic). Parameters checked were WBC count, haemoglobin and differential count, hepatic function tests such as SGOT, SGPT, ALP, bilirubin, creatinine, blood urea nitrogen, total protein, albumin, globulin and renal function tests such as blood urea nitrogen and creatinine, electrolytes such as sodium, potassium, bicarbonate and chloride. No impairment in hepatic, renal, haemopoietic functions were observed throughout the study. Histopathological analysis revealed that liver, kidney, spleen and thymus tissues of treated groups did not show any signs of toxicity. However, astrocytes showed mild hyperplasia, stroma showed oedema in the treated group. Cerebellum also shows stromal oedema. Rasagandhi Mezhugu (RM) administration for one year to HIV patients did not produce any toxicity as seen from liver function and renal function as well as analyzing haematological parameters. Analysis of the metal content in the tissues of RGM treated rats for one month indicated that there was significant accumulation of mercury and copper in the tissues, which indicate that RGM administration for long period of times can produce heavy metal toxicity which is also indicated in histopathological analysis.
机译:印度南部流行的Sidha药物含有大量的重金属。据称这些药物的制备方式降低了它们的毒性。但是,很少进行Sidha制剂的毒性研究。在本研究中,我们评估了Rasagandhi Mezhugu(RM)(一种Sidha制剂)对Wistar大鼠的毒性。药物以单剂(急性)和六十剂(慢性)口服。检查的参数为白细胞计数,血红蛋白和差异计数,肝功能检查(例如SGOT,SGPT,ALP,胆红素,肌酐,血尿素氮,总蛋白,白蛋白,球蛋白)和肾功能检查(例如血尿素和肌酐,电解质等)如钠,钾,碳酸氢盐和氯化物。在整个研究中,未观察到肝,肾,造血功能受损。组织病理学分析显示,治疗组的肝,肾,脾和胸腺组织未显示任何毒性迹象。然而,在治疗组中,星形胶质细胞显示轻度增生,间质显示浮肿。小脑也显示间质水肿。从肝功能和肾功能以及分析血液学参数来看,对HIV患者服用Rasagandhi Mezhugu(RM)一年都没有产生任何毒性。对RGM治疗的大鼠组织中的金属含量进行了1个月的分析,结果表明组织中汞和铜的累积量很大,这表明RGM长期服用会产生重金属毒性,这在组织病理学中也有说明。分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号